Primed smooth muscle cells acting as first responder cells in disease
Preprint
Abstract
Rationale: Vascular smooth muscle cell (VSMC) dysregulation is a hallmark of vascular disease, including atherosclerosis. In particular, the majority of cells within atherosclerotic lesions are generated from pre-existing VSMCs and a clonal nature has been documented for VSMC-derived cells in multiple disease models. However, the mechanisms underlying the generation of oligoclonal lesions and the phenotype of proliferating VSMCs are unknown. Objective: To understand the cellular mechanisms underlying clonal VSMC expansion in disease. Methods and Results: Here we analyse clonal dynamics in multi-color lineage-traced animals over time after vessel injury. We demonstrate that VSMC proliferation is initiated in a small fraction of VSMCs that initially expand clonally in the medial layer and then migrate to form the oligoclonal neointima. Selective activation of VSMC proliferation also occurs in vitro , suggesting that this is a cell-autonomous feature. Mapping of VSMC trajectories using single-cell RNA-sequencing reveals a continuum of cellular states after injury and suggests that VSMC proliferation initiates in cells that have downregulated the contractile phenotype and show evidence of pronounced phenotypic switching. We show that proliferation is associated with induced expression of stem cell antigen 1 (SCA1) and the expression signature previously identified in SCA1+ VSMCs in healthy arteries. A remarkably increased proliferation of SCA1+ VSMCs, directly validated in functional assays, indicates that SCA1+ VSMCs act as “first responders” in vascular injury. Early atherosclerotic lesions also had clonal VSMC contribution and we show that the proliferation-associated injury response is conserved in plaque VSMCs, extending these findings to atherosclerosis. Finally, we identify VSMCs in healthy human arteries that correspond to the SCA1+ state in mouse VSMCs and show that genes identified as differentially expressed in this human VSMC subpopulation are enriched for genes showing genetic association with cardiovascular disease. Conclusions: We show that cell-intrinsic, selective VSMC activation drives clonal proliferation after injury and in atherosclerosis. Our study suggests that healthy mouse and human arteries contain VSMCs characterised by expression of disease-associated genes that are predisposed for proliferation. Targeting such “first responder” cells in patients undergoing vascular surgery could effectively prevent injury-associated VSMC activation and neoatherosclerosis.Keywords
All Related Versions
- Published version: Cardiovascular Research, 119 (5), 1279.
This publication has 40 references indexed in Scilit:
- The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular diseaseFrontiers in Physiology, 2014
- Unravelling stem cell dynamics by lineage tracingNature Reviews Molecular Cell Biology, 2013
- Detection of histone modifications at specific gene loci in single cells in histological sectionsNature Methods, 2013
- Smooth Muscle Cell Apoptosis Promotes Vessel Remodeling and Repair via Activation of Cell Migration, Proliferation, and Collagen SynthesisArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- SDF-1α Induction in Mature Smooth Muscle Cells by Inactivation of PTEN Is a Critical Mediator of Exacerbated Injury-Induced Neointima FormationArteriosclerosis, Thrombosis, and Vascular Biology, 2011
- Intestinal Crypt Homeostasis Results from Neutral Competition between Symmetrically Dividing Lgr5 Stem CellsCell, 2010
- G12-G13–LARG–mediated signaling in vascular smooth muscle is required for salt-induced hypertensionNature Medicine, 2007
- Regulation and characteristics of vascular smooth muscle cell phenotypic diversityNetherlands Heart Journal, 2007
- Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.Proceedings of the National Academy of Sciences, 1992
- Alterations in population dynamics of arterial smooth muscle cells during atherogenesisExperimental and Molecular Pathology, 1976